Actavis acquires Dutch company PharmaPack International
(Thomson Reuters ONE) -
CEO Claudio Albrecht: "This brings us more flexibility and has
a very positive cost impact for Actavis"
Zug, Switzerland, 2 December 2011 - Actavis Group, the international generic
pharmaceuticals company, has acquired 100% of the shares in PharmaPack
International B.V. for an undisclosed amount. PharmaPack is based in Zoetermeer,
the Netherlands, and is a specialist in packaging pharmaceutical as well as
biotechnological products. The company has extensive experience with product,
organisational and country-specific packaging requirements and has been involved
in the pharmaceutical service industry for almost 30 years.
"I have known this professional company for a long time and I am very proud that
the owners decided to choose Actavis as their new partner. It is obvious that
they had other opportunities as well," said Actavis CEO and Chairman Claudio
Albrecht. "This acquisition gives Actavis much greater flexibility in tender
markets and allows for minimum order quantities for smaller markets."
Actavis buys a considerable amount of tablets from third-party manufacturers.
"The lead times are sometimes between six and nine months and therefore much too
long. With the acquisition of PharmaPack International we are able to reduce
these lead times by more than 50 per cent," added Albrecht. One of the Dutch
company's future roles will be the bulk packaging of pharmaceuticals produced in
the Actavis facility in Alathur (India). Another advantage of this packaging
centre will be a significant reduction in freight costs. In summary, PharmaPack
International will increase the Group's cost competitiveness and have a very
positive impact on Actavis' working capital.
Gerard Stevers, Director and owner of PharmaPack International, said he is
convinced that the important and well-considered decision to sell the company
will secure the future of the employees of PharmaPack. "PharmaPack will benefit
from the global organisation of Actavis and have a great opportunity to grow
within this international group." He added that Actavis has very dynamic growth
plans for the future and this expansion will have very positive effects for
PharmaPack. "Actavis will need even more capacity for their packing processes
and are thinking about expanding this facility."
About Actavis Group:
Actavis is the world's fourth largest generic pharmaceutical company. It
specialises in the development, manufacture and sale of generic pharmaceuticals.
The Company has operations in more than 40 countries, with over 10,000
employees. Actavis operates 14 manufacturing sites in 12 different countries
with a total manufacturing capacity of 24 billion tablets/capsules per annum.
For further information on Actavis Group, please visitwww.actavis.com.
About PharmaPack International:
PharmaPack International has been involved in the pharmaceutical service
industry for almost 30 years. In 1983, the company started out as a
pharmaceutical contract packager in Rijswijk, the Netherlands. Thanks to their
efficient production process, good price-quality ratio and great delivery
performance, PharmaPack international developed into one of the largest
pharmaceutical packers in Europe, as well as a market leader in the Netherlands.
In 1998, successful growth necessitated a move to larger premises in Zoetermeer,
where the company is able to provide optimum service in a well-equipped business
environment. PharmaPack supports its customers by means of the "one-stop
shopping" principle, offering a complete solution - from bulk sampling and
storage, to the sourcing of packaging materials and release of end products for
transport.
PharmaPack's services in brief:
* Primary packaging: blisters, containers, hospital packages (unit dose),
buckets, bulk packaging, deblistering
* Secondary packaging: vials, inhalers, kitting, manual packaging,
repackaging, labelling
* Purchase of all necessary packaging components
* Bulk sampling and quarantine storage
* Packaging and storage of opiates class 1 and 2
* Climate controlled storage and worldwide distribution
* Packaging for clinical trial
* Complete (cold) supply chain solutions
* Secondary packaging of cytostatics and (anti-)hormones
# # # #
Enquiries
Actavis Group
Frank Staud
EVP Corporate Communication
Tel: +41 79 230 95 78
E-mail:fstaud(at)actavis.com
Any statements contained in this press release that refer to Actavis' estimated
or anticipated future results or future activities are forward-looking
statements which reflect the Company's current analysis of existing trends,
information and plans. These forward-looking statements are subject to a number
of risks and uncertainties that could cause actual results to differ materially
depending on factors such as the availability of resources, the timing and
effect of regulatory actions, the success of new products, the strength of
competition, the success of research and development issues, unexpected contract
breaches or terminations, exposure to product liability and other lawsuits, the
effect of currency fluctuations and other factors.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Actavis via Thomson Reuters ONE
[HUG#1568380]
Unternehmensinformation / Kurzprofil:
Datum: 02.12.2011 - 09:01 Uhr
Sprache: Deutsch
News-ID 93428
Anzahl Zeichen: 6264
contact information:
Town:
Hafnarfjordur
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 197 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Actavis acquires Dutch company PharmaPack International"
steht unter der journalistisch-redaktionellen Verantwortung von
Actavis (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
